A new translocation (4;12)(q21;q15) after combined immunosuppressive therapy in a case of hypoplastic myelodysplastic syndrome with translocation (12;15)(q23;q12) [2]

Cancer Genetics and Cytogenetics

Volumn 107, Issue 1, 1998, Pages 82-84

  Iwanaga, Masako ^b   Sadamori, Naoki ^b   Amenomori, Tatsuhiko ^b   Kawaguchi, Yasuhisa ^a   Nakamura, Hideo ^a   Matsuo, Tatsuki ^a   Kuriyama, Kazutaka ^a   Tomonaga, Masao ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; BONE MARROW HYPOPLASIA; CASE REPORT; CHROMOSOME 12Q; CHROMOSOME 15Q; CHROMOSOME 4Q; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 4; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

ANEMIA, REFRACTORY; ANTILYMPHOCYTE SERUM; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 4; COMBINED MODALITY THERAPY; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KARYOTYPING; MALE; METHYLPREDNISOLONE; MIDDLE AGED; TRANSLOCATION, GENETIC;

EID: 0032213658     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00083-1     Document Type: Letter

References (12)

1. 1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C, The French-American-British (FAB) Co-operative Group (1982): Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189-199.
2. 2. Nöel P, Tefferi A, Pierre RV, Jenkins RB, Dewald GW (1993): Karyotypic analysis in primary myelodysplastic syndrome. Blood Rev 7:10-18.
3. 3. Lim SW, Falk RE, Look RM, Fuerst MM, Lawrence GN, Kusuanco DA, Giles FJ (1996): Translocation (12;15)(p13;q13) in a patient with relapsed acute myeloid leukemia. Cancer Genet Cytogenet 86:165-167.
4. 4. Butler MG (1990): Prader-Willi syndrome: current understanding of cause and diagnosis. Am J Med Genet 35:319-332.
5. 5. Harada H, Harada Y, Eguchi M, Dohy H, Kamada N (1997): Characterization of acute leukemia with t(4;12). Leuk Lymphoma 25:47-53.
6. 6. Nakamura T, Alder H, Gu Y, Prasad R, Canaani O, Kamada N, Gale RP, Lange B, Crist WM, Nowell PC, Croce CM, Cannani E (1993): Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. Proc Natl Acad Sci USA 90:4631-4635.
7. 7. Mitelman F (1994): Catalog of Chromosome Aberrations in Cancer. ed 5, Wiley-Liss, New York.
8. 8. Bacigalupo A, Broccia G, Corda G, Arcese W, Carotenuto M, Gallamini A, Locatelli F, Mori PG, Saracco P, Todeschini G, Coser P, Iacopino P, van Lint MT, Glickman E (1995): Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party. Blood 85:1348-1353.
9. 9. Biesma DH, van den Tweel, Verdonck LF (1997): Immunosuppressive therapy for hypoplastic myelodysplastic syndrome. Cancer 79:1548-1551.
10. 10. Imai Y, Fukuoka T, Nakatani A, Ohsaka A, Takahashi A (1996): Sustained trilineage recovery and disappearance of abnormal chromosome clone in a patient with myelodysplastic syndrome following combination therapy with cytokines (granulocyte colony-stimulating factor and erythropoietin) and high-dose methylprednisolone. Br J Haematol 93:146-150.
11. 11. Negrin RS, Stein R, Vardiman J, Doherty K, Cornwell J, Krantz S, Greenberg PL (1993): Treatment of anemia of myelodysplastic syndrome using recombinant human granulocyte colony-stimulating factor in combination with erythropoietin. Blood 82:737-743.
12. 12. Horiike S, Misawa S, Nakai H, Kaneko H, Yokota S, Taniwaki M, Yamane Y, Inazawa J, Abe T, Kashima K (1994): N-ras mutation and karyotypic evolution are closely associated with leukemic transformation in myelodysplastic syndrome. Leukemia 8:1331-1336.